The release of3H-noradrenaline by p- and m-tyramines and -octopamines, and the effect of deuterium substitution in α-position
The3H-noradrenaline-releasing effects of p- and m-tyramines and -octopamines, either deuterated or not, were studied in isolated vasa deferentia of the rat (COMT inhibited and calcium-free solution in all experiments).
Km, for uptake1 was higher for octopamines than for tyramines, but not increased by the introduction of deuterium in α-position, except for (probably contaminated) deuterated p-octopamine. Other tissues were preloaded with3H-noradrenaline. After inhibition of vesicular uptake and MAO equi-releasing concentrations of the eight amines were strictly correlated withKm, they were 6 to 7 times higher for unsubstituted octopamines than for corresponding tyramines. When only MAO (but not vesicular uptake) was inhibited, this difference decreased to about 4-fold, but the releasing potency of the deuterated amines (relative to their parent amines) remained unchanged (except for p-octopamine). When vesicular uptake and MAO were intact, unsubstituted octopamines were only 1.5 to 2.2 times less potent than the corresponding tyramines. Analysis of the efflux of3H-DOPEG confirmed that this gain in the relative potencies of octopamines is due to their increased ability to mobilize vesicular 3H-noradrenaline; moreover, deuterated amines as well were then better mobilizers than were their parent amines.
It is concluded that, provided vesicular uptake is intact, the introduction of a \-OH-group enhances the ability of indirectly acting sympathomimetic amines to mobilize vesicular noradrenaline; the introduction of deuterium in α-position, on the other hand, enhances this mobilizing effect exclusively when MAO is intact.
Key wordsIndirectly acting sympathomimetic amines Tyramine Octopamine Deuterium in α-position Rat vas deferens Noradrenaline outward transport
Abbreviations used here
column chromatographic fraction containingall O-methylated metabolites
Unable to display preview. Download preview PDF.
- Belleau B, Moran J (1963) Deuterium isotope effects in relation to the chemical mechanisms of monoamine oxidase. Ann NY Acad Sci 107:822–839Google Scholar
- Belleau B, Burba J, Pindell M, Reiffenstein J (1961) Effect of deuterium substitution in sympathomimetic amines on adrenergic responses. Science 133:102–104Google Scholar
- Bönisch H, Trendelenburg U (1987) Veratridine-induced outward transport of3H-noradrenaline from adrenergic nerves of the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 336:621–630Google Scholar
- Bönisch H, Trendelenburg U (1988) The mechanism of action of indirectly acting sympathomimetic amines. In: Trendelenburg U, Weiner N (eds) Catecholamines. I. Handbook Exp Pharmacol, vol 90/1. Springer, Berlin Heidelberg New York Tokyo, pp 247–277Google Scholar
- Celuch SM, Juorio AV (1987) Effects of deuterium substitution on the chronotropic responses to some sympathomimetic amines in the isolated rat atria. Naunyn-Schmiedeberg's Arch Pharmacol 336:391–395Google Scholar
- Dyck LE, Durden DA, Boulton AA (1986) Effects of deuterium substitution on the catabolism of \-phenylethylamine: an in vivo study. J Neurochem 46:399–404Google Scholar
- Graefe K-H, Stefano FJE, Langer SZ (1973) Preferential metabolism of3H-(−)-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol 22:1147–1160Google Scholar
- Grohmann M, Trendelenburg U (1983) The isotope effect of tritium in 3H-(−)-adrenaline with very high specific activity. NaunynSchmiedeberg's Arch Pharmacol 324:233–234Google Scholar
- Grohmann M, Trendelenburg U (1984) The substrate specificity of uptake2 in the rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 328: 164–173Google Scholar
- Grohmann M, Henseling M, Cassis L, Trendelenburg U (1986) Errors introduced by a tritium label in position 8 of catecholamines. Naunyn-Schmiedeberg's Arch Pharmacol 332: 34–42Google Scholar
- Iversen LL (1967) The uptake and storage of noradrenaline in sympathetic nerves. Cambridge University Press, Cambridge, UKGoogle Scholar
- Langeloh A, Trendelenburg U (1987) The mechanism of the3H-noradrenaline releasing effect of various substrates of uptake1 role of monoamine oxidase and of vesicularly stored3H-noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 336: 611–620Google Scholar
- Langeloh A, Bönisch H, Trendelenburg U (1987) The mechanism of the3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport. Naunyn-Schmiedeberg's Arch Pharmacol 336:602–610Google Scholar
- Michalke W, Langer R, Burger A (1987) Mobilization of biogenic amines from chromaffin-granule ghosts by indirectly acting sympathomimetic amines. Naunyn-Schmiedeberg's Arch Pharmacol 335:R81Google Scholar
- Parker EM, Cubeddu LX (1986) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. J Pharmacol Exp Ther 237:193–203Google Scholar
- Parker EM, Cubeddu LX (1988) Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245:199–210Google Scholar
- Schömig E, Trendelenburg U (1987) Simulation of outward transport of neuronal3H-noradrenaline with the help of a two-compartment model. Naunyn-Schmiedeberg's Arch Pharmacol 336:631–640Google Scholar
- Snedecor GW, Cochran WG (1980) Statistical methods, 7th edn. Iowa State University Press, USAGoogle Scholar
- Stute N, Trendelenburg U (1984) The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 327:124–132Google Scholar
- Trendelenburg U, Stefano FJE, Grohmann M (1983) The isotope effect of tritium in3H-noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 323:128–140Google Scholar
- Yu PH, Barclay S, Davis BA, Boulton AA (1981) Deuterium isotope effects on the enzymatic oxidative deamination of trace amines. Biochem Pharmacol 30:3089–3094Google Scholar
- Yu PH, Kazakoff C, Davis BA, Boulton AA (1982) Deuterium isotope effect on the enzymatic oxidation of dopamine and serotonin. Biochem Pharmacol 31:3697–3698Google Scholar